Month: <span>October 2020</span>

Home / 2020 / October
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
Post

Latin America’s embrace of an unproven COVID treatment is hindering drug trials

Unchecked ivermectin use in the region is making it difficult to test the anti-parasite drug’s effectiveness against the coronavirus. Emiliano Rodríguez Mega Peru (a hospital in Iquitos shown here) has been one of the nations hit hardest by the COVID-19 pandemic. As much of the world waits for an effective vaccine to curb the COVID-19...

UK to begin trials infecting healthy volunteers with COVID in early 2021
Post

UK to begin trials infecting healthy volunteers with COVID in early 2021

By Rich Haridy, October 20, 2020 The first stage of the trial will be infecting healthy volunteers with the virus to discover the lowest dose that consistently leads to the development of COVID-19 Researchers in the United Kingdom are set to undertake controversial human challenge trials to accelerate the testing of COVID-19 vaccines. The trials, planned to commence...

Diagnostic, therapeutic advance for rare neurodegenerative disorder
Post

Diagnostic, therapeutic advance for rare neurodegenerative disorder

by Lynda De Widt,  Mayo Clinic Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3)—a disease that has no cure. They also have clarified the role of a gene target associated with the disease. The inherited disease is linked to a mutation in...

Study discovers potential target for treating aggressive cancer cells
Post

Study discovers potential target for treating aggressive cancer cells

by Kerry Benson,  Brown University As researchers and medical professionals work to develop new treatments for cancer, they face a variety of challenges. One is intratumor heterogeneity—the presence of multiple kinds of cancer cells within the same tumor. Often, these “mosaic” tumors include cells, such as polyploidal giant cancer cells, that have evolved to become aggressive and resistant...

A wearable sensor to help ALS patients communicate
Post

A wearable sensor to help ALS patients communicate

by  Massachusetts Institute of Technology All of the components in the sensor device are easy to mass-produce, so the researchers estimate that each device would cost around $10. People with amyotrophic lateral sclerosis (ALS) suffer from a gradual decline in their ability to control their muscles. As a result, they often lose the ability to speak,...

Bacterial metabolism of dietary soy may lower risk factor for dementia
Post

Bacterial metabolism of dietary soy may lower risk factor for dementia

by  University of Pittsburgh Associate professor of epidemiology, University of Pittsburgh Graduate School of Public Health. A metabolite produced following consumption of dietary soy may decrease a key risk factor for dementia—with the help of the right bacteria, according to a new discovery led by researchers at the University of Pittsburgh Graduate School of Public Health. Their study,...

Evidence found of link between gut microbe deficiency and autism spectrum disorder
Post

Evidence found of link between gut microbe deficiency and autism spectrum disorder

by Bob Yirka , Medical Xpress A team of researchers affiliated with a host of institutions in China has found evidence of a gut microbe deficiency in children who develop autism spectrum disorder (ASD). In their paper published in the journal Science Advances, the group describes their study of gut microbes in ASD children and what they found....

Can scientists take the STING out of common respiratory viruses?
Post

Can scientists take the STING out of common respiratory viruses?

by  University of North Carolina at Chapel Hill School of Medicine University of North Carolina School of Medicine scientists have made a curious discovery about a well-known human protein that helps the immune system fight viral infections. The lab of Stan Lemon MD, and colleagues found that one class of viruses actually requires this protein to...

New blood cancer treatment works by selectively interfering with cancer cell signalling
Post

New blood cancer treatment works by selectively interfering with cancer cell signalling

by  University of Alberta Faculty of Medicine & Dentistry University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published today in Nature Communications. The research team led by Luc Berthiaume, cell biology professor in the Faculty of Medicine & Dentistry,...